The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The new online Learning Center with new content can still be found under the “Training” folder on ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...